• Busca persones
• Intranet

Clínica aplicada en neoplàsies hematològiques Beatriz Bellosillo

Publicacions 2026 (18)

• Rocha P, Gibert J, Menéndez S, del Rey-Vergara R, Iñañez A, Masfarre-Pinto L, Navarro N, Ríos-Hoyo A, Perez S, Taus A, Giner M, Rovira A, León Mateos L, Isla D, Paz-Ares L, Zugazagoitia J, Martí-Blanco C, Garcia-Campelo R, Moreno Vega A, Callejo Á, Rojo F, Sanchez I, Arriola E^*. Brief report: Artificial intelligence meets small cell lung cancer-integrating clinicopathological and wholeslide image data for prognostic prediction in SCLC. Frontiers In Artificial Intelligence And Applications 2026; 9: 1766576 (Acceptat).
  Cites:0
  Cites:0
• Rodriguez D, Melero J^*, Pont A, Calvet V, Ruiz G, Campana L, Raya MC, Jiménez C, Vila E, Rodriguez U, Bartolome D, Del Arco A, Vilá G, Isart A, Manzano D, Lafuente J. Tranexamic acid in spinal surgery: a stratified protocol from the surgeon's point of view. 2026; 6: 105989 (Acceptat).
  Cites:0
  Cites:0
• Domínguez-García JJ^*, Escamilla MS, Garcia-Avila S, López-Pereira B, Martín-Sánchez G, Cortés-Vázquez MA, Calvo-Sánchez JA, Fernández-García S, Vega-Suárez LP, Ocio-San Miguel EM, Bermúdez-Rodríguez MA, Yañez-San Segundo L. Factors associated with long-term quality of life after allogenic stem cell transplantation. Leukemia Lymphoma 2026; 66(14): 2733-2740.
  Cites:0
  Cites:0
• López Pereira P^*, Romero-Domínguez S, Martin Moro F, Caballero AC, Lopez-García A, de la Cruz-Benito B, Franch-Sarto M, de la Cruz F, López-Marín J, Pinzon SF, Jiménez-Ubieto A, Cabirta A, Gutiérrez NC, Lis-Chulvi MJ, Puyuelo A, Muntañola A, Penedo-Coello A, García-Lerma E, Mercadal-Vilchez S. Outcomes of de novo primary central nervous system lymphoma using the MATRix regimen for induction followed by thiotepa-based conditioning: a GELTAMO analysis. Bone Marrow Transplant 2026; 61(2): 229-231.
  Cites:1
  Cites:1
• Ribera JM^*, Torrent A, Morgades M, Barrena S, Ribera J, Genescà E, González Campos J, Martínez Cibrian N, Montesinos P, Hernández-Sánchez A, Barba P, Zapico e Sr, Sánchez R, Novo A, Sitges M, Maluquer artigal C, Such E, Botella C, Queipo de Llano MP, Cabrero M, Vicent A, Lopez-de Ugarriza P, Tormo M, Gonzalez Gonzalez BJ, García-Cadenas I, Rodríguez-Medina C, Martínez-Sánchez P, Bermudez A, Gómez Centurión I, Herrero Garcia M, Ciudad J, Navas Acosta J, Hermosin L, Serrano J, Raposo-Puglia JÁ, Solán L, Roldán Galiacho V, De laiglesia A, Gomez-Perez L, Solé M, Casado MS, Llorente gonzalez L, Barrios decoud D, Vall-Llovera F, Algarra JL, Amador L, García-Boyero R, Cladera A, Bergua Burgues JM, Calasanz MJJ, Granada I, Feliu E, Hernandez Rivas JM, Orfao A. Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia. Blood 2026: (en Premsa).
• Iglesias Coma M^*, Badia J, Martínez Ciarpaglini C, Linares J, Tarazona N, Mulet-Margalef N, Tornero Piñero P, Sallent A, Recort-Bascuas A, Gibert J, Sant-Albors M, Tauriello DVF, Cruz M, Carreras M, Sancho E, Morral Martinez C, Garrido M, Manzano-Mozo JL, Cervantes A, Montagut C, Batlle E^*, Calon A^*. Stromal biomarker-based framework for identifying pMMR/MSS and dMMR/MSI colorectal cancers with poor outcomes and limited benefit from immunotherapy. Gut 2026: (en Premsa).
  Cites:0
  Cites:0
• Hodson DJ^*, Shouse G^*, Shin HJ, Salar A, Bobillo S, Ribrag V, Macpherson NA, Córdoba R, Kim JS, Guidez S, Herrera AF, Morschhauser F, Colton D, Izuzquiza M, Sambamurthy N, Munugalavadla V, Vicente S, Gorgun G, Chen R, Younes A, Wang ML. Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (CAPITAL). Clin Cancer Res 2026; 32(5): 859-868.
  Cites:0
  Cites:0
• Huguet M, Morgades M, Rivas-Delgado A, Bastos-Oreiro M, Córdoba R, Salar A, de la Cruz F, Alcoceba M, Ferrer-Lores B, Jiménez-Ubieto A, Gutiérrez A, Infante M, Huerga S, Abrisqueta P, Cruz D, Montalbán C, Muntañola A, González-Villambrosia S, Ribera JM, Navarro JT^*. Validation of prognostic scores in patients with HIV-related diffuse large B-cell lymphoma: The value of peripheral blood parameters-A study from the Spanish Lymphoma Group GELTAMO. Br J Haematol 2026; 208(3): 1111-1115.
  Cites:0
  Cites:0
• Mingot-Castellano ME^*, Alcalde Mellado P, Entrena-Ureña L, Pascual-Izquierdo C, Zafra-Torres D, Canaro-Hirnyk M, Bastida JM, Bernat-Pablo S, Martínez-Carballeira D, Caparrós-Miranda IS, Cuesta García A, Lakhwani S, Sánchez-González B, Canet Maldonado M, Gómez del castillo solano MD, García Culebras M, Chiclana Rodríguez B, Fernández Villalobos M, Sánchez Llorca P, Piquer Monsonís D, Puerta Vázquez C, Pérez Montes R, Garcia-Pallarols F, Poza Santaella M, Pedrote-Amador B, Spanish ITP Group (GEPTI). Combining an immunomodulatory drug with a TPO-RA to treat multirefractory ITP patients: The Spanish ITP Group experience. Br J Haematol 2026; 208(3): 1036-1045.
  Cites:1
  Cites:1
• Mingot Castellano ME^*, Álvarez Román MT, Bastida JM, Butta N, Caballero Navarro G, Canaro-Hirnyk M, Entrena-Ureña L, Gómez del castillo solano MD, Ramirez Lopez A, Sánchez-González B, Valcárcel-Ferreiras D, Pascual-Izquierdo C. Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia. J Clin Med 2026; 15(6): 2273.
  Cites:0
  Cites:0
• Santaliestra M^*, Garrote M, Fernández-Rodríguez MC, Vélez P, Senín A, Arellano-Rodrigo E, Garcia N, Longarón R, Pérez Encinas M, Caballero-Navarro G, Noya Pereira MS, Cuevas B, Gómez-Casares MT, Stuckey R, Carreño-Tarragona G, Ferrer-Marín F, Cortes MA, Magro E, Mata I, Angona A, Perez R, Fox ML, Pastor-Galán I, Sastre P, Triguero A, García-Gutiérrez V, Hernández-Boluda JC, Bellosillo B, Álvarez-Larran A. Response to therapy and prognosis according to molecular characterization in CALR-mutated essential thrombocythemia. Hemasphere . 2026; 10(3): e70325 (Acceptat).
  Cites:0
  Cites:0
• Lafuente M, Diez-Feijoo R, García Recio M, Garcia N, Fernández-Rodríguez MC, Longarón R, Ji J, Tazón-Vega B, Pinzon SF, Fernández-Ibarrondo L, Sánchez-González B, Camacho L, Gibert J, Gutiérrez A, Bellosillo B, Salar A^*. Tumor Mutational Burden as a Prognostic Biomarker in Follicular Lymphoma. Cancers 2026; 18(5): 737.
  Cites:0
  Cites:0
• Solé L, Canton E, Maqueda M, Lobo T, Barbachano A, Torres F, Cabré Romans JJ, Montoto Á, Fernández-Ibarrondo L, Martínez-García D, Guix M, Larrubia-Loring M, Montagut C, Muñoz A, Bigas A, Iglesias Coma M, Bellosillo B, Espinosa L^*. ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumors. Br J Cancer 2026; 134(4): 638-649.
  Cites:0
  Cites:0
• Díaz-González Á^*, Mora E^*, Garrote M, Carreño-Tarragona G, Salido M, Pastor-Galán I, Stuckey R, Cisneros A, Domingo-Monfort JA, Uresandi-Iruin N, Argoitia-Ituarte N, Avetisyan G, Garcia-Ruiz C, Torres-Hernández N, Furió S, Arellano-Rodrigo E, Alvarez N, Vélez P, Villamon E, Segura-Díaz A, Ayala R, Espinet B, Álvarez-Larran A, Hernández-Boluda JC, Such E. Optical genome mapping in myelofibrosis: enhancing prognostic accuracy through high-resolution genomic profiling. Blood Adv 2026; 10(2): 379-391.
  Cites:0
  Cites:0
• Chatzikonstantinou T, Mikhaleva M, Brieghel C, Papangelou C, Minga E, Arrais-Rodrigues C, Besikli-Dimou S, Cerutti A, Doubek M, Enggaard L, Espinet B, Ferrer-Lores B, García Vela JA, Gentile M, Gimeno E, Gutwein O, Herishanu Y, Jablonowska-Babij P, Jaksic O, Josefsson P, KaliciNska E, Kislova M, Lista E, Kotsianidis I, Marquet J, Martino EA, Mcauley C, Mela-Osorio MJ, Moia R, Mosquera C, Nikitin E, Pavlovsky MA, Pfister V, Savas EM, Scarfo L, Sever M, Shvidel L, Simkovic M, Stavroyianni N, Talimtzi P, Tranidou A, Visentin A, Vrachiolias G, Wasik-Szczepanek E, Wróbel T, Yagci M, Cellini A, Chatzidimitriou A, Gaidano G, Anderson MA, Davids MS, Brown J, Niemann CU, Stamatopoulos K, Ghia P^*, Ahn IE^*, Koren-Michowitz M. Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL. Blood Adv 2026; 10(2): 428-438.
  Cites:0
  Cites:0
• Fiallo-Suárez DV^*, Stuckey R^*, Bilbao-Sieyro C, Tapia Torres M, Pérez-Ortíz L, Fernandez F, Borsani O, Rumi E, Ianotto JC, Lekovic D, Ferrer-Marín F, Cuevas B, Kandula Z, Gasior M, Álvarez-Larran A, Lewandowski K, Senín A, Drozd-Sokolowska J, Sobas MA, Santoro M, Foncillas MA, Hernández-Boluda JC, Angona A, Carreño Gomez-Tarragona G, Mata-Vazquez MI, Fox ML, Del Orbe-Barreto R, Vélez P, Vallansot R, Lemes-Castellano A, Gómez-Casares MT, Polish Acute Leukemia Group (PALG) and MPN Spanish Group (GEMFIN). Coexisting Myeloproliferative and Lymphoid Neoplasms: A European Multicenter Retrospective Study. Am J Hematol 2026; 101(1): 156-159.
  Cites:0
  Cites:0
• Sehn LH^*, Hubel K, Luminari S, Scholz CW, Salar A, Paneesha S, Wahlin BE, Panayiotidis P, Lee HP, Jiménez-Ubieto A, Sancho JM, Kim TM, Domingo-Doménech E, Kumode T, Poh C, Thieblemont C, Deeren D, DE WIT E, Arbushites M, Vassallo I, Trneny M, inMIND Study team. Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial. Lancet 2026; 407(10524): 133-146.
  Cites:9
  Cites:9
• Charalampopoulou S, Ramos-Campoy S, Duran M, Puiggros A, Kamaso J, Nguyen-Khac F, Rigolin GM, Cuneo A, Collado R, García-Serra R, Haferlach C, Ortega M, Abrisqueta P, Bosch F, Zenz T, Blanco ML, Salgado R, García Malo M, Gimeno E, López-Guillermo A, Campo E, Etter L, Schoumans J, Espinet B^*, Martín Subero JI^*. Identification of two epitypes of IGHV unmutated chronic lymphocytic leukemia with distinct B-cell-related epigenetic imprinting and genetic alterations. Hemasphere . 2026; 10(1): e70211 (Acceptat).
  Cites:0
  Cites:0